Health IT

With new FDA clearances for 7-day wear and precise 1-unit dosing, CeQur's Simplicity patch is poised to disrupt the diabetes tech market. A deep dive.

Scispot's Series A targets the messy 'coordination gap' in labs. It's a bet that before we get self-driving labs, we must first fix the data pipes.

VSP Vision Care's 2026 top ranking signals a growing focus on vision insurance for both financial savings and proactive physical health management.

James Walker explores how Delta's new integrated solutions, from AI drones to IAQ sensors, are redefining healthcare and hospitality spaces for a new era.

With its world-first gastric cancer drug heading for approval, Innovent Biologics isn't just offering new hope—it's executing a masterclass in strategic leverage.

KAYTUS's MotusAI promises to slash AI costs by managing tokens on-prem. Is this the key to unlocking ROI and data sovereignty for agentic AI?

A new lifestyle brand, XOXO Far From Home, is betting its vibrant Butterfly Latte can do more than quench thirst—it aims to build a community in a crowded market.

As CEO Reshma Kewalramani takes the stage, investors will look for clues on how Vertex plans to pivot from CF dominance to a multi-franchise powerhouse.

A new partnership with Scala.AI aims to move beyond simple telehealth, using deep operational intelligence to fix healthcare's costly fragmentation and poor navigation.

dltHub's recent Snowflake award isn't just a trophy. It signals a tectonic shift where AI automates the complex plumbing of the digital economy.

Eyebot and The Framery's new partnership offers 15-minute prescriptions via mall kiosks, blending tech and retail. But can this model truly disrupt the optical industry?

Marking 10 years, Wellpoint Iowa's $5M+ investment in community programs reveals a strategic playbook for tackling the social drivers of health.

For patients with fragile bones, spinal fusion is a high-stakes gamble. A new device offers a lifeline by anchoring screws with cement, but what does it mean for safety?

With a new CEO known for scaling software firms, STARLIMS is betting big on agentic AI and M&A to dominate the mission-critical lab informatics market.

The market for T-cell malignancy treatments is set to surpass $1.8B, fueled by a pipeline of innovative drugs aiming to meet vast unmet patient needs.

By appointing Dr. James Augustine, ImageTrend signals a critical shift: the future of emergency AI will be built on frontline experience, not just code.

Zepto Life Technology's FDA Breakthrough status for a fungal test isn't just a win for patients; it's a strategic move in liquid biopsy's new frontier.

A new partnership uses healthcare data expertise to guide military caregivers through a mental health crisis. But is this innovative solution enough?

With a severe shortage of addiction specialists, one treatment provider is launching a university. Is this the model to scale expertise and finally turn the tide?

The men's supplement industry is shifting from pure performance to holistic vitality. A new launch reveals the economic and scientific forces driving this change.